The characterization of mobile colistin resistance (


Journal

Microbial genomics
ISSN: 2057-5858
Titre abrégé: Microb Genom
Pays: England
ID NLM: 101671820

Informations de publication

Date de publication:
02 2020
Historique:
pubmed: 1 2 2020
medline: 14 8 2020
entrez: 1 2 2020
Statut: ppublish

Résumé

To establish the prevalence of mobile colistin resistance (

Identifiants

pubmed: 32003708
doi: 10.1099/mgen.0.000331
pmc: PMC7067213
doi:

Substances chimiques

Anti-Bacterial Agents 0
Bacterial Proteins 0
Colistin Z67X93HJG1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Bioinformatics. 2015 Oct 15;31(20):3350-2
pubmed: 26099265
Bioinformatics. 2010 Mar 1;26(5):589-95
pubmed: 20080505
J Antimicrob Chemother. 2016 Aug;71(8):2326-7
pubmed: 27029849
Antimicrob Agents Chemother. 2017 Apr 24;61(5):
pubmed: 28223389
J Antimicrob Chemother. 2017 Apr 1;72(4):1253-1255
pubmed: 28031273
mBio. 2017 Jun 27;8(3):
pubmed: 28655818
Clin Infect Dis. 2005 May 1;40(9):1333-41
pubmed: 15825037
Sci Rep. 2017 Nov 10;7(1):15364
pubmed: 29127343
Nat Methods. 2012 Mar 04;9(4):357-9
pubmed: 22388286
Bioinformatics. 2018 Sep 1;34(17):3028-3029
pubmed: 29659710
Bioinformatics. 2014 Jul 15;30(14):2068-9
pubmed: 24642063
Antimicrob Agents Chemother. 2018 May 25;62(6):
pubmed: 29760138
Bioinformatics. 2012 Feb 15;28(4):464-9
pubmed: 22199388
Trends Genet. 2014 Sep;30(9):401-7
pubmed: 25096945
Euro Surveill. 2017 Aug 3;22(31):
pubmed: 28797325
J Antimicrob Chemother. 2017 Oct 1;72(10):2745-2749
pubmed: 29091227
Genome Res. 2010 Sep;20(9):1297-303
pubmed: 20644199
Nat Commun. 2018 Mar 21;9(1):1179
pubmed: 29563494
mBio. 2019 May 7;10(3):
pubmed: 31064835
Bioinformatics. 2014 Aug 1;30(15):2114-20
pubmed: 24695404
Bioinformatics. 2014 May 1;30(9):1312-3
pubmed: 24451623
J Clin Microbiol. 2012 Mar;50(3):709-20
pubmed: 22205822
Zoonoses Public Health. 2015 Mar;62(2):151-8
pubmed: 24931512
J Antimicrob Chemother. 2018 May 1;73(5):1433-1435
pubmed: 29444245
J Antimicrob Chemother. 2018 Jul 1;73(7):1791-1795
pubmed: 29912417
PeerJ. 2016 Aug 17;4:e2308
pubmed: 27602279
BMJ. 2017 Sep 5;358:j2291
pubmed: 28874360
PLoS Comput Biol. 2017 Jun 8;13(6):e1005595
pubmed: 28594827
Emerg Microbes Infect. 2018 Apr 4;7(1):55
pubmed: 29615602
Euro Surveill. 2017 Aug 3;22(31):
pubmed: 28797324
Euro Surveill. 2016 Jul 7;21(27):
pubmed: 27416987
BMC Genomics. 2011 Aug 08;12:402
pubmed: 21824423
J Comput Biol. 2012 May;19(5):455-77
pubmed: 22506599
Antimicrob Agents Chemother. 2014 Jul;58(7):3895-903
pubmed: 24777092
Antimicrob Resist Infect Control. 2017 Sep 6;6:91
pubmed: 28878890
Bioinformatics. 2014 Dec 1;30(23):3399-401
pubmed: 25143291
Bioinformatics. 2013 Apr 15;29(8):1072-5
pubmed: 23422339
Genome Res. 2004 Jul;14(7):1394-403
pubmed: 15231754
Antimicrob Agents Chemother. 2017 Feb 23;61(3):
pubmed: 28031198
PLoS Pathog. 2012;8(6):e1002776
pubmed: 22737074
Antimicrob Agents Chemother. 2017 Jun 27;61(7):
pubmed: 28416554
Antimicrob Agents Chemother. 2016 Jun 20;60(7):4351-4
pubmed: 27090180
Emerg Microbes Infect. 2018 Jul 4;7(1):122
pubmed: 29970891
J Antimicrob Chemother. 2017 Dec 1;72(12):3317-3324
pubmed: 28962028
Euro Surveill. 2017 Aug 3;22(31):
pubmed: 28797329
Bioinformatics. 2009 Aug 15;25(16):2078-9
pubmed: 19505943
J Antimicrob Chemother. 2016 Aug;71(8):2300-5
pubmed: 27090630
J Antimicrob Chemother. 2017 Feb;72(2):393-401
pubmed: 28073961
Microbiome. 2017 Jul 6;5(1):70
pubmed: 28683827
Curr Med Res Opin. 2015 Apr;31(4):707-21
pubmed: 25697677
Bioinformatics. 2011 Apr 1;27(7):1009-10
pubmed: 21278367

Auteurs

Cheryll M Sia (CM)

University of Leicester, Leicester, LE1 7RH, UK.

David R Greig (DR)

National Infection Service, Public Health England, London, NW9 5EQ, UK.

Martin Day (M)

National Infection Service, Public Health England, London, NW9 5EQ, UK.

Hassan Hartman (H)

National Infection Service, Public Health England, London, NW9 5EQ, UK.

Anais Painset (A)

National Infection Service, Public Health England, London, NW9 5EQ, UK.

Michel Doumith (M)

King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
Infectious Diseases Research Department, King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.

Daniele Meunier (D)

National Infection Service, Public Health England, London, NW9 5EQ, UK.

Claire Jenkins (C)

National Infection Service, Public Health England, London, NW9 5EQ, UK.

Marie Anne Chattaway (MA)

National Infection Service, Public Health England, London, NW9 5EQ, UK.

Katie L Hopkins (KL)

National Infection Service, Public Health England, London, NW9 5EQ, UK.

Neil Woodford (N)

National Infection Service, Public Health England, London, NW9 5EQ, UK.

Gauri Godbole (G)

National Infection Service, Public Health England, London, NW9 5EQ, UK.

Timothy J Dallman (TJ)

National Infection Service, Public Health England, London, NW9 5EQ, UK.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH